Streetbeat News

Price Targets

GCMG

Oppenheimer analyst Chris Kotowski has maintained an Outperform rating on GCM Grosvenor (NASDAQ:GCMG), but lowered the price target from $12 to $11.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:42 pm

DAN

Oppenheimer analyst Noah Kaye maintains an Outperform rating on Dana (NYSE:DAN) but has lowered the price target from $21 to $17.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:41 pm

CG

Oppenheimer analyst Chris Kotowski maintains an Outperform rating on Carlyle Group (NASDAQ:CG) but lowers the price target from $58 to $53.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:40 pm

BWA

Oppenheimer analyst Noah Kaye has maintained an 'Outperform' rating on BorgWarner (NYSE:BWA), but lowered the price target from $48 to $45.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:38 pm

APTV

Oppenheimer analyst Colin Rusch has reiterated an Outperform rating on Aptiv (NYSE:APTV) and maintained a price target of $149.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:37 pm

AMGN

Oppenheimer analyst Jay Olson maintains an Outperform rating on Amgen (NASDAQ:AMGN) and raises the price target from $280 to $290.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 3:35 pm

GOVX

HC Wainwright & Co. analyst Vernon Bernardino has reiterated a 'Buy' rating on Geovax Labs (NASDAQ:GOVX) and maintained an $8 price target.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 2:56 pm

LAUR

Jefferies analyst Pedro Baptista has initiated coverage on Laureate Education (NASDAQ:LAUR) with a Buy rating and a price target of $20.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 2:46 pm

WST

West Pharmaceutical Servs Inc. (NYSE:WST) shares are currently trading at $376.13, after a 0.38% decrease. Over the past month, the stock decreased by 4.49%, but over the past year, it increased by 56.93%. The company's P/E ratio is 54.96, lower than the Life Sciences Tools & Services industry average of 61.01, indicating potential undervaluation or weaker future performance.

Portfolio Pulse from Benzinga Insights

October 09, 2023 | 2:45 pm

TRV

Citigroup analyst Michael Ward has maintained a Neutral rating on Travelers Companies (NYSE:TRV) and lowered the price target from $191 to $181.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2023 | 2:45 pm